Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy
NCT04324866 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2020-03-27
Summary
This study will assess the prevalence and incidence of COVID-19 infection in patients with chronic plaque psoriasis on immunosuppressant therapy.
Conditions
- Coronavirus Infection
Interventions
- DIAGNOSTIC_TEST
-
Nasopharyngeal swab
Nasopharyngeal swab for the molecular diagnosis of COVID-19 infection
Sponsors & Collaborators
-
Azienda Ospedaliera Universitaria Integrata Verona
collaborator OTHER -
Universita di Verona
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-04-01
- Primary Completion
- 2020-11-30
- Completion
- 2020-12-31
More Related Trials
-
Clinical Assessment and Psychosocial Impact of Psoriasis
NCT01964443 ·Status: COMPLETED
-
Sulodexide in Controlling the Recurrence of Psoriasis
NCT06982196 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
NCT00236171 ·Status: COMPLETED ·Phase: NA
-
Comparative Analysis of Small and Large Plaque Psoriasis
NCT01920906 ·Status: COMPLETED ·Phase: NA
-
Effect of Long-term Psoriasis on Patients' Life - CORONATE
NCT05555953 ·Status: COMPLETED
-
Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis
NCT00438360 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis
NCT04693936 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The DIET Trial - Dietetic Intervention in Psoriatic Arthritis
NCT03142503 ·Status: COMPLETED ·Phase: NA
-
Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)
NCT06792487 ·Status: RECRUITING
-
A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis
NCT03210961 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00428974 ·Status: COMPLETED ·Phase: PHASE2
-
Improvement of Psoriasis Patients' Adherence to Topical Drugs
NCT04220554 ·Status: COMPLETED ·Phase: NA
-
A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis
NCT03971825 ·Status: TERMINATED ·Phase: PHASE1
-
Differential Clinical and Serologic Response in Psoriasis and Psoriatic Arthritis to Drug Treatment
NCT00451243 ·Status: COMPLETED
-
A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis
NCT01276639 ·Status: COMPLETED ·Phase: PHASE3
-
AGN-242428 in the Treatment of Plaque Psoriasis
NCT03339999 ·Status: TERMINATED ·Phase: PHASE2
-
Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test
NCT02432027 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02514577 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Repeat Courses of IM Alefacept
NCT00233662 ·Status: COMPLETED ·Phase: PHASE3
-
Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
NCT00606450 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
NCT03832738 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis
NCT01815424 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety, Tolerability and Efficacy of BCT194 in Healthy Volunteers and Patients With Psoriasis.
NCT00417820 ·Status: COMPLETED ·Phase: PHASE1
-
Topical Double-blind, Randomized, Placebo-controlled Study in Psoriasis Patients
NCT01936337 ·Status: COMPLETED ·Phase: PHASE2
-
1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to Mapracorat
NCT03399526 ·Status: COMPLETED ·Phase: PHASE1